72 Investment Holdings’s Alto Neuroscience ANRO Stock Holding History

72 Investment Holdings’s Portfolio ANRO Stock Details ANRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$15M	Hold	667,778	–	–	30.26%	2
2025 Q4	$11.9M	Hold	667,778	–	–	23.5%	3
2025 Q3	$2.68M	Hold	667,778	–	–	3.95%	4
2025 Q2	$1.47M	Hold	667,778	–	–	3.83%	4
2025 Q1	$1.44M	Hold	667,778	–	–	4.05%	4
2024 Q4	$2.82M	Hold	667,778	–	–	5.75%	4
2024 Q3	$7.64M	Hold	667,778	–	–	16.42%	3
2024 Q2	$7.14M	Hold	667,778	–	–	17.94%	3
2024 Q1	$10.3M	Buy	+667,778	New	+$10.5M	15.28%	3

Other funds holding ANRO

AWG

Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

SSC

Spruce Street Capital New York $416M AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

72 Investment Holdings's ANRO Position: Q1 2026 in Review

72 Investment Holdings held its Alto Neuroscience (ANRO) position steady in Q1 2026 at 667,778 shares worth $15M. The position accounts for 30.26% of the portfolio, ranked #2.

72 Investment Holdings first reported a position in ANRO in Q1 2024 and has held it in 9 quarters since. 110 funds tracked by Wall St. Rank hold ANRO as of Q1 2026.

72 Investment Holdings held 667,778 shares of Alto Neuroscience worth $15M as of Q1 2026.
72 Investment Holdings left its Alto Neuroscience share count unchanged in Q1 2026.
Alto Neuroscience made up 30.26% of 72 Investment Holdings's portfolio in Q1 2026, its #2 holding.
72 Investment Holdings first reported a position in Alto Neuroscience in Q1 2024 and has held it in 9 quarters since.
110 funds tracked by Wall St. Rank held Alto Neuroscience as of Q1 2026.

Based on 72 Investment Holdings's 13F filing for Q1 2026, filed 15 May 2026.